1. Home
  2. PAHC vs ORGO Comparison

PAHC vs ORGO Comparison

Compare PAHC & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • ORGO
  • Stock Information
  • Founded
  • PAHC 1946
  • ORGO 1985
  • Country
  • PAHC United States
  • ORGO United States
  • Employees
  • PAHC N/A
  • ORGO N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • ORGO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAHC Health Care
  • ORGO Health Care
  • Exchange
  • PAHC Nasdaq
  • ORGO Nasdaq
  • Market Cap
  • PAHC 700.3M
  • ORGO 665.8M
  • IPO Year
  • PAHC 2014
  • ORGO N/A
  • Fundamental
  • Price
  • PAHC $17.99
  • ORGO $4.56
  • Analyst Decision
  • PAHC Sell
  • ORGO Buy
  • Analyst Count
  • PAHC 4
  • ORGO 2
  • Target Price
  • PAHC $21.00
  • ORGO $5.50
  • AVG Volume (30 Days)
  • PAHC 220.8K
  • ORGO 1.5M
  • Earning Date
  • PAHC 05-07-2025
  • ORGO 05-08-2025
  • Dividend Yield
  • PAHC 2.72%
  • ORGO N/A
  • EPS Growth
  • PAHC 30.53
  • ORGO N/A
  • EPS
  • PAHC 0.48
  • ORGO N/A
  • Revenue
  • PAHC $1,106,080,000.00
  • ORGO $482,043,000.00
  • Revenue This Year
  • PAHC $27.84
  • ORGO $3.31
  • Revenue Next Year
  • PAHC $10.22
  • ORGO $12.50
  • P/E Ratio
  • PAHC $37.78
  • ORGO N/A
  • Revenue Growth
  • PAHC 12.63
  • ORGO 11.29
  • 52 Week Low
  • PAHC $12.30
  • ORGO $2.17
  • 52 Week High
  • PAHC $26.55
  • ORGO $6.71
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 42.54
  • ORGO 54.84
  • Support Level
  • PAHC $16.16
  • ORGO $4.11
  • Resistance Level
  • PAHC $18.35
  • ORGO $4.68
  • Average True Range (ATR)
  • PAHC 1.14
  • ORGO 0.35
  • MACD
  • PAHC 0.10
  • ORGO 0.05
  • Stochastic Oscillator
  • PAHC 52.97
  • ORGO 89.66

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: